Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: drkaz who wrote (3355)	12/12/2014 12:22:42 PM
From: donpat	Respond to of 12871

Looks like that reference you noted is the first: einstein.yu.edu Ebola virus Researchers Find "Key" Used by Ebola Virus to Unlock Cells and Spread Deadly Infection *Findings Published in Nature* Could Lead to Drugs that Thwart Outbreaks August 24, 2011 — (Bronx, NY) —** Researchers at Albert Einstein College of Medicine of Yeshiva University have helped identify a cellular protein that is critical for infection by the deadly Ebola virus. The findings, published in today's online edition of Nature, suggest a possible strategy for blocking infection due to Ebola virus, one of the world's most lethal viruses and a potential bioterrorism agent. The study was a collaborative effort involving scientists from Einstein, the Whitehead Institute for Biomedical Research, Harvard Medical School, and the U.S. Army Medical Research Institute of Infectious Diseases [AKA USAMRIID].